EPAM vs STRO · P/E 14, rev $4.73B vs rev $62.0M
EPAM Systems Inc (EPAM) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported EPAM revenue for 2024-12-31 was $4.73B. Net income was $454.5M. Revenue was up 0.8% from 2023-12-31 to 2024-12-31. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
EPAM currently screens at market cap $5.10B and trailing P/E 14.0. STRO currently screens at market cap $470.8M.
Not investment advice. Open the EPAM and STRO stock pages for the full models.
Not investment advice.